SHP2 sails from physiology to pathology

European Journal of Medical Genetics
Mylène TajanArmelle Yart

Abstract

Over the two past decades, mutations of the PTPN11 gene, encoding the ubiquitous protein tyrosine phosphatase SHP2 (SH2 domain-containing tyrosine phosphatase 2), have been identified as the causal factor of several developmental diseases (Noonan syndrome (NS), Noonan syndrome with multiple lentigines (NS-ML), and metachondromatosis), and malignancies (juvenile myelomonocytic leukemia). SHP2 plays essential physiological functions in organism development and homeostasis maintenance by regulating fundamental intracellular signaling pathways in response to a wide range of growth factors and hormones, notably the pleiotropic Ras/Mitogen-Activated Protein Kinase (MAPK) and the Phosphoinositide-3 Kinase (PI3K)/AKT cascades. Analysis of the biochemical impacts of PTPN11 mutations first identified both loss-of-function and gain-of-function mutations, as well as more subtle defects, highlighting the major pathophysiological consequences of SHP2 dysregulation. Then, functional genetic studies provided insights into the molecular dysregulations that link SHP2 mutants to the development of specific traits of the diseases, paving the way for the design of specific therapies for affected patients. In this review, we first provide an overvie...Continue Reading

References

Dec 1, 1988·European Journal of Pediatrics·M B RankeJ R Bierich
Jul 26, 1995·Biochemical and Biophysical Research Communications·J A BoniniC Hofmann
Jun 2, 1995·The Journal of Biological Chemistry·S F HausdorffM J Birnbaum
Jul 19, 1994·Proceedings of the National Academy of Sciences of the United States of America·A M BennettB G Neel
May 24, 1994·Proceedings of the National Academy of Sciences of the United States of America·P PeraldiE Van Obberghen
Aug 30, 1996·The Journal of Biological Chemistry·J M ArrandaleD U Rabin
Nov 1, 1996·Biochemical and Biophysical Research Communications·H MaegawaR Kikkawa
Mar 10, 1998·Cell·P HofS E Shoelson
Oct 9, 1999·The Journal of Biological Chemistry·H MaegawaA Kashiwagi
Dec 14, 1999·Molecular and Cellular Biology·A M O'ReillyB G Neel
Apr 28, 2001·Molecular and Cellular Endocrinology·D M OuwensJ A Maassen
Jan 10, 2002·The Journal of Biological Chemistry·Jess M CunnickJie Wu
May 2, 2002·The Journal of Biological Chemistry·Giuseppe BifulcoCarmine Nappi
Sep 13, 2002·American Journal of Physiology. Lung Cellular and Molecular Physiology·D TefftD Warburton
Jun 27, 2003·Trends in Biochemical Sciences·Benjamin G NeelLily Pao
Aug 19, 2003·The Journal of Biological Chemistry·Toshiyuki ArakiBenjamin G Neel
Oct 16, 2003·Molecular and Cellular Biology·Yehenew M Agazie, Michael J Hayman
Dec 3, 2003·Blood·Mignon L LohKevin M Shannon
May 4, 2004·Journal of Medical Genetics·A SarkozyB Dallapiccola
Jun 1, 2004·Molecular and Cellular Biology·Maria I KontaridisAnton M Bennett

❮ Previous
Next ❯

Citations

Jan 26, 2016·Seminars in Cell & Developmental Biology·Pawan Puri, William H Walker
Feb 24, 2016·European Journal of Endocrinology·Catie CessansThomas Edouard
May 31, 2016·European Journal of Medical Genetics·Henk van den BergJan de Lange
Mar 18, 2017·Current Opinion in Hematology·Ruchi PandeyReuben Kapur
Jan 24, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Enis KostallariVijay H Shah
Dec 6, 2017·Molecular and Cellular Biology·Alexander James Hale, Jeroen den Hertog
Jun 21, 2018·Endocrine Reviews·Mylène TajanArmelle Yart
Nov 18, 2018·Journal of Thrombosis and Haemostasis : JTH·M HuH Hu
Aug 14, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jie ZhangYuehai Ke
Nov 10, 2017·Current Opinion in Endocrinology, Diabetes, and Obesity·Armelle Yart, Thomas Edouard
Sep 22, 2016·Oncotarget·Ruo-Yu ZhangZhong-Yin Zhang
Dec 13, 2016·JCI Insight·Jae-Sung YiAnton M Bennett
Mar 23, 2017·American Journal of Medical Genetics. Part a·Aurore SiegfriedMarie-Bernadette Delisle
Aug 19, 2017·Scientific Reports·Atsushi HijikataTsuyoshi Shirai
Mar 31, 2019·Nature Communications·Charlène NiogretGreta Guarda
Mar 14, 2020·BMC Medical Genetics·Jeevana Praharsha AthotaSwathi Shetty
Apr 14, 2020·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Heng ZhouQi-Zhu Tang
Apr 14, 2017·Neuropathology and Applied Neurobiology·Q ZhangL-C Ang
Jul 31, 2018·Expert Review of Endocrinology & Metabolism·Alberto J SchuhmacherCarmen Guerra
Jun 16, 2019·Journal of Cell Science·Yohan KimGloria Lee
Jun 20, 2019·Frontiers in Molecular Neuroscience·Liang QuYuan Wang
Mar 7, 2020·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Hyun-Hee RyuYong-Seok Lee
Nov 12, 2019·Frontiers in Immunology·Charlène NiogretGreta Guarda
Nov 17, 2020·Chemical Biology & Drug Design·Rati Kailash Prasad Tripathi, Senthil Raja Ayyannan
Sep 10, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yuta AdachiHiromichi Ebi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cardiac Regeneration

Cardiac regeneration enables the repair of irreversibly damaged heart tissue using cutting-edge science, including stem cell and cell-free therapy. Discover the latest research on cardiac regeneration here.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Cardiovascular Homeostasis

Cardiovascular regulation and homeostasis is important in maintaining health and dysfunction may lead to cardiovascular diseases. Nitric oxide and vascular endothelium are one of many molecules involved in the homeostatic mechanism. Here is the latest research on cardiovascular homeostasis.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.